The Corporate and Commercial Litigation Practice of Anderson Kill & Olick, P.C. has been selected by Pfizer Inc. as one of the Company’s partner law firms to handle commercial litigation matters.

Anderson Kill participated in Pfizer's Partnering Program ("P3") for outside counsel and was one of a selected few law firms chosen to partner with Pfizer for such work out of a large field of applicants. Anderson Kill’s selection is a recognition of the firm’s:exceptional legal expertise demonstrated litigation and trial skills ability to tailor creative approaches to legal problems ability to resolve matters efficiently, finding alternative solutions and effectively managing the legal team zealous advocacy, team availability and understanding of our client’s goals commitment to our client’s values of diversity and pro bono serviceAnderson Kill is proud to have met the high standards of Pfizer’s rigorous P3 partnership program. We are particularly pleased to be recognized as a practice that combines the highest level of litigation expertise with the responsiveness and service orientation of a boutique.  Anderson Kill & Olick’s Corporate and Commercial Litigation Practice is nationally recognized for its ability to deliver practical, efficient and innovative solutions to the variety of litigation and alternative dispute resolution issues confronting businesses today.  The Department’s 35 attorneys are skilled litigators and trial lawyers experienced in practice areas including antitrust and unfair competition, class action, bankruptcy and financial services, securities, product liability, and real estate.Anderson Kill & Olick, P.C. is a national law firm with offices in New York City, Greenwich, Newark; Philadelphia; and Washington, D.C.  More information about the firm and its nine practice groups can be found at www.andersonkill.info. For more information, please contact:Carol A. UeckermanCommunications/Marketing Manager(212) 278-1339cueckerman@andersonkill.com